Overview

Dxcover is a clinical-stage diagnostics company developing AI-enabled liquid biopsy tests for earlier cancer detection. Its proprietary platform combines infrared spectroscopy with AI to analyse the full biochemical signature of blood, capturing both tumour and host-response signals. With one of the largest spectral multiomic datasets globally and the first regulatory approval of its kind, Dxcover is scaling across the UK, EU, and US to deliver accessible, high-throughput cancer diagnostics